Multidivisional enterprise operating across energy, technology, aerospace, healthcare, finance, and 40+ global industries.
Revenue driven by strong performance in Aerospace and Digital Systems divisions.
EARNINGSClinical trials show 94% efficacy in rare genetic disorders, stock rises 4%.
HEALTHCARE$12B deal with EU consortium marks milestone in clean energy transition.
ENERGY